The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.
To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.
For additional information please review our Privacy Policy.
Alexandria, Va. — A newly updated guideline from the American Society of Clinical Oncology (ASCO) states that post-menopausal women who are at increased risk for breast cancer could benefit from taking either tamoxifen or raloxifene to reduce their risk of developing the disease.
Alexandria, Va. –ASCO and The ASCO Cancer Foundation is honoring 11 community oncology practices for their efforts to improve care of people with cancer through increasing and enhancing patient participation in cancer clinical trials.
Alexandria, Va.—The ASCO Cancer Foundation will award more than $6.1 million to support clinical and translational research designed to improve cancer prevention, treatment and care. The grants will be awarded to 63 researchers at the American Society of Clinical Oncology’s 45th Annual Meeting in Orlando, May 29 – June 2.
ALEXANDRIA, Va. —The American Society of Clinical Oncology (ASCO) awarded $10,000 grants to five of its State and Regional Affiliates to fund projects that address the varying needs of oncologists and people with cancer in their communities.
Alexandria, Va. — The American Society of Clinical Oncology (ASCO) released the results of a survey of medical oncology and hematology/oncology fellowship program directors, which found training programs have limited plans to increase the number of oncology training positions over the next five years.
Alexandria, Va.—George W. Sledge Jr., MD, a pioneer in the development of novel therapies for breast cancer, has been elected to become President of the American Society of Clinical Oncology (ASCO) for a one-year term beginning in June 2010. He will take office as President-Elect during ASCO’s 45th Annual Meeting in Orlando in June 2009. Additionally, six new members were elected to the ASCO Board of Directors and two new members to the ASCO Nominating Committee, all for three-year terms beginning in June 2009.
Hollywood, FL— New research on the rapidly advancing field of molecular cancer markers was released today in advance of the second Annual Meeting on Molecular Markers in Cancer, being held October 30-November 1 in Hollywood, FL. The meeting is co-sponsored by the American Society of Clinical Oncology, the National Cancer Institute and the European Organisation for Research and Treatment of Cancer.
Alexandria, VA— Organizers of the 2008 Annual Meeting on Molecular Markers in Cancer today announced the winners of the Symposium Merit Awards. Nineteen physicians-in-training will receive funding to assist with their travel to attend the meeting, to be held October 30 – November 1 in Hollywood, FL.
Alexandria, Va. – Researchers will discuss molecular markers’ potential to further improve and personalize the treatment of people with cancer during an embargoed presscast (press briefing via live webcast) on October 28, 2008, at 12:00 PM (EDT), in advance of the 2008 Annual Meeting on Molecular Markers in Cancer.
Chicago, IL—Two plenary studies and other research evaluating screening and treatment options for patients with lung and testicular cancer were released today at a press briefing for the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO).
